The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The impact of diabetes on survival following breast cancer
Abstract
Purpose It has been suggested that type 2 diabetes may affect breast cancer prognosis, possibly due to increased diabetes-related comorbidity, or direct effects of insulin resistance and/or hyperinsulinemia. The purpose of this study was to examine the impact of diabetes on survival following breast cancer.Methods Using population-based health databases from Ontario, Canada, this retrospective cohort study compared deaths between women with breast cancer aged 55-79 years with diabetes and without diabetes. Women were followed for all cause mortality from breast cancer diagnosis until March 31st 2006.Results Of the 6,107 women with breast cancer, 1,011 had diabetes and 5,096 did not have diabetes. Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, and had greater comorbidity compared to women without diabetes. After a mean follow-up of 5.0 years and adjustment for age, prior mammograms and other covariates, mortality following breast cancer was significantly higher among women with versus without diabetes (hazard ratio, HR 1.39, 95% confidence interval, CI 1.22-1.59, P < 0.0001). The effect of diabetes on mortality was comparable to that seen in women with diabetes without breast cancer over a 7-year follow-up.Conclusion This study found that diabetes was associated with a close to 40% increase in mortality within the first 5 years following breast cancer, which was similar to that seen in women with diabetes without breast cancer. These findings suggest that early survival following breast cancer is reduced in women with diabetes, possibly due to diabetes-related causes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in one study, 5-year mortality rates were significantly higher (hazard ratio 1.39) in patients diagnosed with both breast cancer and diabetes than in comparable breast cancer patients without diabetes (9).”
From Diabetes and Cancer (2010) · cites this paper as [9]
Citations
Cites
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,811
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Hux, J. E., Ivis, F. J., Flintoft, V. F., & Bica, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.512 · Cited by 1,290
Efficacy of screening mammography. A meta-analysis
Kerlikowske, K. M. (1995) · JAMA · doi:10.1001/jama.273.2.149 · Cited by 1,136
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 897
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s37 · Cited by 830
Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J. M., & Thun, M. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh161 · Cited by 795
Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix
Weiner, J. P., Starfield, B. H., Steinwachs, D. M., & Mumford, L. M. (1991) · Medical Care · doi:10.1097/00005650-199105000-00006 · Cited by 677
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–176 of 176
Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
Zhu, Q., Xu, W., & Tao, M. (2010) · Cancers · doi:10.3390/cancers2020721 · Cited by 16
“increase in mortality within the first five-year following breast cancer [16].”
BackgroundWahdan-Alaswad, R. S., & Thor, A. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91183 · Cited by 15
Metformin and Breast Cancer Risk
Gandini, S., Guerrieri‐Gonzaga, A., Puntoni, M., & DeCensi, A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3596 · Cited by 15
Wu, K., Yu, X., Huang, Z., Zhu, D., Yi, X., Wu, Y., Hao, Q., Kemp, K. T., Elshimali, Y., Iyer, R., et al. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7486 · Cited by 15
“Moreover, 5-year mortality rates are notably higher in patients with BC and diabetes versus their nondiabetic counterparts (26).”
Lu, L., Wang, R., Liang, R., Gan, L., Bai, Y., Jin, L., Yao, Z.-X., Liu, S., Ren, G.-S., Wu, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093630 · Cited by 14
Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system
Jian, W., Chen, T., Qin, S., Duan, Y., & Wang, G. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.032 · Cited by 12
Sadighi, S., Amanpour, S., Behrouzi, B., Khorgami, Z., & Muhammadnejad, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.5.2287 · Cited by 12
“Furthermore, diabetic women with breast cancer have worse disease-related clinical outcomes than their nondiabetic counterparts (Lipscombe et al., 2008; Peairs et al., 2011).”
BackgroundAssociation of Type 2 Diabetes Genetic Variants with Breast Cancer Survival among Chinese Women
Bao, P., Zhao, Z., Gao, Y., Zheng, Y., Zhang, B., Cai, H., Zheng, W., Shu, X., & Lu, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117419 · Cited by 11
“It has been reported that 16% to 20% of breast cancer patients had type 2 diabetes (T2D) at time of cancer diagnosis [7, 8] and this comorbidity was inversely associated with breast cancer survival [9, 10, 11, 12, 13].”
BackgroundResultInfluentialZhao, J., Zeng, D., Liu, Y., Luo, Y., Ji, S., Li, X., & Chen, T. (2017) · Metallomics · doi:10.1039/c7mt00001d · Cited by 11
The five-year survival rate of breast cancer at Radiation and Isotopes Centre Khartoum, Sudan
Elhassan, S. I. A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04615 · Cited by 11
Shin, J.-Y., Shim, H.-Y., & Jun, J. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110412 · Cited by 11
Relationship between resting heart rate and metabolic risk factors in breast cancer patients
Lee, M. K., Lee, D. H., Park, S., Kim, S. I., & Jeon, J. Y. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.032 · Cited by 12
“closely related to obesity and metabolic parameters [14–16], it is of importance whether RHR among breast cancer survivors are associated with metabolic parameters [17].”
BackgroundKuwabara, Y., Morishima, T., Odani, S., Kudo, H., Ma, C., Kato, M. S., Koyama, S., Saito, M. K., Nakata, K., Tabuchi, T., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13940 · Cited by 10
López‐de‐Andrés, A., Jiménez‐Trujillo, I., Hernández‐Barrera, V., de Miguel‐Díez, J., Méndez‐Bailón, M., de Miguel-Yanes, J. M., Pérez-Farinós, N., Salinero-Fort, M. Á., del Barrio, J. L., Romero‐Maroto, M., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017676 · Cited by 10
“DIsCussIOn T2DM is considered to be a common comorbidity that is present in many patients with breast cancer, correlating with poor clinical outcomes.(17) 18 According to information obtained from the SNHDD, compared with non-diabetic counterparts, women with T2DM undergoing surgical breast cancer procedures have more…”
Cox Proportional Hazard Survival Analysis to Inpatient Breast Cancer Cases
Bustan, M. N., Arman, A., Aidid, M. K., Gobel, F. A., & Syamsidar, S. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1028/1/012230 · Cited by 10
“In addition to the clinical stage stage of breast cancer or the type of diagnosis, there are several other prognostic factors associated with survival rate, namely: age [16], race [15] , occupation [17], comorbidity: diabetes [18]; anemia [7] [19], family history [7], tumor size [20] [21], location of lymph node metas…”
BackgroundKaur, P., Berchuck, A., Chase, A., Grout, B., Deurloo, C. M., Pearce, L., Pike, M. C., Richardson, J. L., Terry, K. L., Webb, P. M., et al. (2024) · Neoplasia · doi:10.1016/j.neo.2024.101026 · Cited by 9
“The fact that the protective effect of metformin reached statistical significance only within the diabetic cohort may be related to the consistent finding that diabetes is associated with reduced survival after ovarian cancer [25,26].”
BackgroundZakaraya, E. A. Z. (2023) · Periodicals of Engineering and Natural Sciences (PEN) · doi:10.21533/pen.v11.i3.156 · Cited by 9
Sergi, D., Melloni, M., Passaro, A., & Neri, L. M. (2024) · Nutrients · doi:10.3390/nu16193243 · Cited by 9
“Furthermore, different studies have reported that patients with both T2DM and BC have lower overall survival and disease-free survival compared to those without T2DM [187–190].”
BackgroundDiabetes in women – A life-course approach
Morling, J. R., Balkau, B., & Wild, S. H. (2013) · Menopause international · doi:10.1177/1754045313487719 · Cited by 9
“59) compared to those without diabetes (adjusted for age, prior mammograms income and comorbidities).(66) In the USA, similarly, all-cause mortality in breast cancer patients with an HbA1c 7.”
Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort
Liuu, É., Saulnier, P., Gand, E., Ragot, S., Valéro, S., Jamet, A., Hadjadj, S., & Paccalin, M. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01362-9 · Cited by 9
Fadelu, T. A., Damuse, R., Lormil, J. K., Pecan, E., Greenberg, L., Dubuisson, C., Pierre, V., Triedman, S. A., Shulman, L. N., & Rebbeck, T. R. (2020) · JCO Global Oncology · doi:10.1200/go.20.00307 · Cited by 9
Improving health engagement and lifestyle management for breast cancer survivors with diabetes
Shelby, R. A., Dorfman, C. S., Arthur, S. S., Bosworth, H. B., Corsino, L., Sutton, L., Owen, L. J., Erkanli, A., Keefe, F. J., Corbett, C. M., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.105998 · Cited by 10
Plasma levels of glucose and insulin in patients with brain tumors.
Alexandru, O., Ene, L., Os, P., Tache, D. E., Popescu, A., Om, N., Tătăranu, L. G., Georgescu, A. M., Tudorică, Zaharia, C., et al. (2014) · Europe PMC (PubMed Central) · doi:10.12865/chsj.40.01.05 · Cited by 8
“[1] Several studies support the idea that metabolic syndrome may be involved in the etiology, progression or outcome of some cancers like: prostate, colorectal, liver, biliary tract, gallbladder, breast, and endometrial.[1-8] Until now, the data to demonstrate the relationship between metabolic syndrome or it’s compon…”
BackgroundManaging people with diabetes during the cancer palliation in the era of simultaneous care
Ferrari, P., Giardini, A., Negri, E. M., Villani, G., & Preti, P. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.010 · Cited by 8
Late Breast Cancer Survivorship: Side Effects and Care Recommendations
Jahan, N., Cathcart-Rake, E. J., & Ruddy, K. J. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00049 · Cited by 9
Diabetes, diabetes therapies and cancer: what’s the link?
Seewoodhary, J., & Bain, S. C. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411421024 · Cited by 7
Loktionova, M. V., Mohammadian, M., Choopani, R., Kheiri, S., & Mohammadian-Hafshejani, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314565 · Cited by 6
RetractedRodríguez, L. A., Bradshaw, P. T., Parada, H., Khankari, N. K., Wang, T., Cleveland, R. J., Teitelbaum, S. L., Neugut, A. I., & Gammon, M. D. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01292-2 · Cited by 6
Diabetic mortality risk among cancer patients in the United State SEER population, 1975–2016
Zhu, X., Heng, Y., Zhou, L. F., Zhang, M., Cao, P., & Tao, L. (2020) · Endocrine · doi:10.1007/s12020-020-02405-2 · Cited by 6
Screening and Management Recommendations for Type 2 Diabetes in Women With Breast Cancer
Scott, L. J., Truong, L.-L., Houlden, R. L., & Wijeratne, D. T. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.07.008 · Cited by 6
Wolde, H. F., Molla, M. D., Aragie, H., Adugna, D. G., Teferi, E. T., Melese, E. B., Assefa, Y. A., Negash, H. K., Worku, Y. B., Belay, D. G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-36472-y · Cited by 5
Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors
Griffiths, R. I., Lindquist, K. J., O’Malley, C. D., Gleeson, M. L., Duryea, J. L., Valderas, J. M., & Danese, M. D. (2014) · ISRN Oncology · doi:10.1155/2014/607850 · Cited by 5
“Clinical Study Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors Robert I. Griffiths,1,2 Karla J. Lindquist,3 Cynthia D. O’Malley,4 Michelle L. Gleeson,3 Jennifer L. Duryea,3 José M. Valderas,1 and Mark D. Danese3 1 Nuffield Department of Primary Care…”
Moradi-Joo, M., Mohabbat-Bahar, S., Heidari, S., Davoodi, S. H., Sheyklo, S. G., & Akbari, M. E. (2016) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-5971 · Cited by 5
“The results of a study aimed at investigating the diabetes impact on breast cancer risk, reported that, 40% of deaths in the first 5 years after breast cancer have occurred in women with diabetes (5).”
BackgroundSystemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model
Wei, N., Lu, J., Lin, Z., Wang, X., Cai, M., Jiang, S., Chen, X., Zhu, S., Zhang, D., & Cui, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.829798 · Cited by 5
Bloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-0591 · Cited by 5
Manna, S., Banerjee, S., De, A., Banerjee, S., Das, S., Rakshit, P., K, A. K. S., Sen, K. K., & De, S. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385314533240824090949 · Cited by 4
Demırel, P. B., Özorhan, Ü., Tuna, B. G., Cleary, M. P., & Doğan, S. (2019) · Annals of Medical Research · doi:10.5455/annalsmedres.2019.09.542 · Cited by 4
“Since both obesity and type 2 diabetes are related to insulin resistance, the association between obesity, diabetes and breast cancer is attributed mostly to the insulin resistance, which is involved in the worse prognosis of breast cancer in diabetic (4) and obese (6, 7) patients.”
BackgroundAssociation of Adipose Tissue Distribution With Type 2 Diabetes in Breast Cancer Patients
Qi, J., Hu, H. Z., Yaghjyan, L., An, L., Kalim, H. A., Cooke, E. O., & Cheng, T. D. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223420972369 · Cited by 4
Insulin, Insulin Resistance, and Cancer Associations
Lipscombe, L. L. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_5 · Cited by 4
“Five studies have specifically examined the influence of preexisting diabetes on all-cause mortality among breast cancer patients, and all studies have documented a worse survival following breast cancer among patients with diabetes [69, 118–122].”
BackgroundJeong, S., Poudyal, S., Klagges, S., Kuhnt, T., Papsdorf, K., Hambsch, P. K., Wach, J., Güresir, E., Nägler, F., Rühle, A., et al. (2023) · Cancers · doi:10.3390/cancers15194845 · Cited by 3
“Finally, diabetes mellitus (DM) appears to be associated with increased cancer mortality across several primary tumors [31,32].”
BackgroundBREAST CANCER IN WOMEN WITH DIABETES MELLITUS TYPE 2
Вацеба, Т. С., & SOKOLOVA, L. K. (2019) · World of Medicine and Biology · doi:10.26724/2079-8334-2019-2-68-30-34 · Cited by 3
The Epidemiologic Relationship between Diabetes and Cancer
nker, K. S. Z. A. (2008) · Frontiers in diabetes · doi:10.1159/000152026 · Cited by 3
Kuwabara, Y., Morishima, T., Kudo, H., Kato, M. S., Koyama, S., Nakata, K., & Miyashiro, I. (2026) · PLoS ONE · doi:10.1371/journal.pone.0337946 · Cited by 2
Policardo, L., Barchielli, A., Seghieri, G., & Francesconi, P. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0898-1 · Cited by 2
Mao, Y.-W., Zeng, H.-D., Ye, F., Wu, X., Zhang, M.-H., Hu, C.-D., & Zhao, Y.-X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1506629 · Cited by 1
“Lipscombe et al. (60) showed that diabetes was associated with a nearly 40% increase in mortality within the fi rst fi ve years after BC surgery, a rate similar to that of diabetic women without BC.”
Liu, S., Feng, D., Xu, Y., Lin, F., & He, Z. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157819 · Cited by 1
Diabetes Mellitus and Oncology: A Comprehensive Review
Kapoor, M., Kapoor, A., & Kant, R. (2026) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0046-1820120 · Cited by 1
Hershman, D. L., Till, C., Wright, J. D., Ramsey, S. D., Barlow, W. E., & Unger, J. M. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00040 · Cited by 1
Time to follow‐up of an abnormal mammogram in women with diabetes: a population‐based study
Habeeb, S. Y., Fung, K., Fischer, H. D., Austin, P. C., Paszat, L. F., & Lipscombe, L. L. (2016) · Cancer Medicine · doi:10.1002/cam4.892 · Cited by 1
Vigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_12 · Cited by 1
Mouse Models Used to Study the Effects of Diabetes, Insulin, and IGFs on Cancer
Zelenko, Z., LeRoith, D., & Gallagher, E. J. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_8
“associated with decreased breast cancer survival and decreased recurrence free survival [21,22].”
BackgroundExploring a therapeutic role for IGF1R inhibitors in triple-negative breast cancer
Offor, O. (2010) · Europe PMC (PubMed Central)
Hillson, R. (2015) · Practical Diabetes · doi:10.1002/pdi.1919
Should diabetic women with breast cancer have their own intervention studies?
Potter, D. A., Yee, D., Guo, Z., & Rodriguez, M. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0309
“…have been linked to increased breast cancer risk and poor breast cancer outcomes (Coughlin et al. 2004, Xue & Michels 2007, Barone et al. 2008, Lipscombe et al. 2008); and animal models are needed to inform the development of trials testing dietary, exercise, and pharmacologic interventions…”
Participação de Genes Relacionados ao Processo Inflamatório no Diabetes Mellitus Gestacional.
Cézar, N. J. B. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2013.tde-13062013-085547
Original Paper Plasma Levels of Glucose and Insulin in Patients with Brain Tumors
Alexandru, O., Ene, L., Purcaru, O. S., Tache, D. E., Popescu, A., Neamţu, O. M., Tătăranu, L. G., Tudorica, V., Zaharia, C., & Dricu, A. (2016)
Goodwin, R. A., Jamal, R., Booth, C. M., Goss, P. E., Eisenhauer, E. A., Tu, D., & Shepherd, L. E. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.01.014
Impact of Age and Comorbidity on Cervical and Breast Cancer Literacy of
Women, A., & Talley, C. H. (2015)
Alenzi, E. O. (2017) · doi:10.33915/etd.5057
“Many studies have found that among women with BC, DM was associated with 40% higher mortality rate then women without DM (Lipscombe et al., 2008; Luo et al., 2015; Verlato et al., 2003).”
InfluentialMahmoud, A. S., & Bakheit, K. H. (2017) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.17.1323
Rahman, M. R., Afroze, S. R., Sarker, R. S. C., Rahim, M. A., & Uddin, K. N. (2018) · Bangladesh Journal of Medicine · doi:10.3329/bjmed.v28i2.33355
Functions of nuclear receptors in cancer metabolism
와이라구, 페. (2014) · YUHSpace (Yonsei University Medical Library)
Diyabetes Mellitus Ağız Kanserleri İçin Bir Risk Faktörü Mü?
Başaran, M. (2020) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.771272
Influence of Breast Cancer and Metastases on Incidence of DiabetesPreprint
Ballinger, T. J., Liu, Z., El‐Azab, S. A., Broyles, A. A., Guise, T. A., & Imel, E. A. (2021) · Research Square · doi:10.21203/rs.3.rs-191145/v1
Diabetes as the risk of cancer: a literature review
Tedjamartono, T. D. (2021) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20210905
“39 times.(65) Research by Ballotari et al shows that the”
BackgroundVigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-1
Vigneri, R., & Sciacca, L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-2
Vigneri, R., & Sciacca, L. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_12
(2010) · Diabetes Care · doi:10.2337/dc11-s098
Diabetes and Cancer: Treacherous Associations
Saxena, R., Naithani, M., & Saluja, R. (2022) · Journal of Cardio-diabetes and metabolic disorders · doi:10.4103/jcdm.jcdm_9_21
Association between Diabetes Status and Breast Cancer in Us Adults: A Cross-Sectional StudyPreprint
Sun, X., Hu, P., Liu, X., Liu, J., Yan, Y., Sun, C., Yau, V., Lowe, S., Meng, M., & Liu, Z. (2022) · Preprints.org · doi:10.20944/preprints202209.0481.v1
Animal models and age-related diseases
Qu, J.-H. (2023) · Aging Research · doi:10.26599/agr.2023.9340017
Lawrence, W. (2020) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/76w3-wfa9
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J., Kar, S., Zheng, W., Bojesen, S. E., Easton, D., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245820
Escala-Garcia, M., Morra, A., Canisius, S., Chang-Claude, J., Kar, S., Zheng, W., Bojesen, S. E., Easton, D., Pharoah, P. D. P., & Schmidt, M. K. (2020) · Figshare · doi:10.6084/m9.figshare.13245823
COMPARISON OF 18F-FDG PET/CT DATA WİTH TYPE 2 DIABETES AND OBESITY IN BREAST CANCER
Babacan, Ö. U., & Hasbek, Z. (2025) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1696624
Metadata
- Authors
- Lipscombe, L. L., Goodwin, P. J., Zinman, B., McLaughlin, J. R., & Hux, J. E.
- Affiliations
- Institute for Clinical Evaluative Sciences (CA)
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Lipscombe, Lorraine L.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2007-07-21
- Volume
- 109
- Issue
- 2
- Pages
- 389-395
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2025598781
- Cited by
- 176
- References
- 26
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 4 · 2020: 18 · 2019: 5 · 2018: 9 · 2017: 8 · 2016: 15 · 2015: 13 · 2014: 15 · 2013: 11 · 2012: 14
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- type 2 diabetes, breast cancer, survival, mortality, comorbidities, insulin resistance, hyperinsulinemia, prognosis, women
- MeSH terms
- Aged, Breast Neoplasms, Diabetes Mellitus, Type 2, Female, Humans, Middle Aged, Diabetes Complications, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
